TwentyTwentyTweets
Tweets by 2020health-
Join 7,195 other subscribers
-
Recent Posts
Pages
Tag Archives: patent box
Pharmaceutical Industry- Innovation is the only way forward.
The headline news from the Health and Social Care Information Centre (HSCIC) states that more than 1 billion prescription items were dispensed by community pharmacies in England for the first time in 2012. However, we must not be complacent about the serious … Continue reading
Guest Blogspot – The UK Needs More Biotechnology Companies
The success of US biotechnology companies contrasts sharply with the disappointment in other countries. British companies valued by stock markets at more than about US $ 4 billion go in the FTSE 100 index. There are no biotechnology companies big … Continue reading
Posted in Business, Drugs, Emerging technologies, Finance, Genetics, Pharma, Policy, Research, Technology
Tagged 2020health, Amgen, biotechnology, biotechnology company, block-buster, blockbuster, BTG, drug pricing, Genentech, genetics, medicine, Nobel Prize, patent box, pharmaceutical, pricing, R&D, R&D tax credit, Research, value-based, value-based pricing
1 Comment
Guest Blogspot- Dept. of Health Consultation on Drug Pricing: “A new value-based approach to the pricing of branded medicines”
The Department of Health deadline for public submissions on pharmaceutical pricing is this Thursday. Many pitfalls must be avoided if the Government’s proposals are to form the basis of a successful drug pricing policy. Some problems are not easy to … Continue reading
Posted in Andrew Lansley, Business, competition, Department of Health, Drugs, NHS, Pharma, Policy, Research, Uncategorized
Tagged 2020health, Andrew lansley, competition, David Jack, Department of Health, Drugs, health, innovation, innovative, medicine, National Health Service, NHS, parallel export, parallel import, patent box, pharmaceutical, PPRS, pricing, R&D, R&D tax credit, Research, unmet, unmet clinical need, unmet healthcare need, unmet medical need, value-based, value-based pricing, winner takes all
3 Comments
Guest Blogspote: How to encourage pharmaceutical R&D
Politicians should only attempt the possible. We must recognise what we cannot do. The UK Government alone cannot influence the direction of R&D significantly. The sums of money involved are so vast that R&D only makes sense in a global … Continue reading
Posted in Andrew Lansley, Business, competition, Department of Health, Drugs, Health Bill, Hospitals, Innovation, NHS, Pharma, Policy, Research, Uncategorized, White Paper
Tagged 2020health, Andrew lansley, biotechnology, breakthrough, Clinical trials, competition, Department of Health, Equity and Excellence, health, Health Bill, medicine, National Health Service, NHS, NICE, patent box, Pfizer, pharmaceutical, pricing, R&D, R&D tax credit, Research, university, value-based, value-based pricing, wholesaler
Leave a comment
2020health's Blog 